The OCTET study, 10 an RCT that found no differences in hospitalization, illustrates the issues. First, OCTET did not compare CTO against no CTO but, for ethical reasons, two forms of compulsory care. Second, patients who ''really needed'' a CTO were excluded by their psychiatrists, because being randomized to the non-CTO group would have been unethical. Third, patients not capable of consenting (probably most of those on CTOs in Canada) were excluded from the study. 11 Fourth, 33% of eligible patients chose not to participate-the very group for whom CTOs are designed. 12 Fifth, 21% of the patients randomized to the CTO group were not put on a CTO. Sixth, 24% of the patients randomized to be discharged without a CTO had to be transferred to a CTO. Needless to say, no drug study with such a high percentage of protocol violations would be used to conclude that a drug was ineffective. Seventh, the findings cannot be generalized to other jurisdictions because of the marked differences in legislation that affect clinical practice.
Swanson and Swartz, 13 who reviewed CTO studies, conclude, ''In our view, such evidence is sufficient to justify more widespread implementation of outpatient commitment, accompanied where possible by systematic local evaluations similar to the New York assisted outpatient treatment study.'' We agree.
Yours truly,
